Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.6380
0.00 (0.00%)
At close: Mar 12, 2026, 4:00 PM EDT
0.6380
0.00 (0.00%)
After-hours: Mar 12, 2026, 8:00 PM EDT

MTNB Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
5.447.284.796.8321.0312.43
Short-Term Investments
--8.9721.9328.5946.25
Cash & Short-Term Investments
5.447.2813.7628.7649.6258.68
Cash Growth
-49.65%-47.05%-52.18%-42.04%-15.43%111.26%
Other Current Assets
0.220.741.795.771.372.88
Total Current Assets
5.658.0315.5434.5350.9961.55
Net Property, Plant & Equipment
1.512.165.015.735.784.86
Other Intangible Assets
2.262.263.023.023.023.02
Goodwill
--1.341.341.341.34
Other Long-Term Assets
0.270.20.20.20.20.2
Total Assets
9.712.6425.144.8261.3370.97
Accounts Payable
0.080.10.510.620.940.35
Accrued Expenses
0.561.811.453.12.852.8
Current Portion of Leases
0.850.770.660.570.560.42
Total Current Liabilities
1.52.672.624.294.353.57
Long-Term Leases
1.482.132.93.564.143.33
Other Long-Term Liabilities
0.260.260.340.340.340.34
Total Long-Term Liabilities
1.742.393.243.94.483.67
Total Liabilities
3.245.055.868.188.837.24
Preferred Stock
-----3.8
Common Stock
00-0.020.020.02
Additional Paid-in Capital
215.33207.41195.04190.07184.25167.19
Accumulated Other Comprehensive Income
---0.22-0.82-0.150.23
Retained Earnings
-208.88-199.82-175.57-152.63-131.63-107.51
Shareholders' Equity
6.467.5919.2536.6452.4963.73
Total Liabilities & Equity
9.712.6425.144.8261.3370.97
Total Debt
2.332.893.564.124.73.75
Net Cash (Debt)
3.14.3910.224.6444.9254.93
Net Cash Growth
-29.36%-56.96%-58.60%-45.15%-18.22%133.28%
Net Cash Per Share
0.600.902.355.6810.6913.95
Book Value
6.467.5919.2536.6452.4963.73
Book Value Per Share
1.251.564.438.4512.4916.18
Tangible Book Value
4.25.3314.8932.2848.1459.38
Tangible Book Value Per Share
0.811.103.437.4511.4515.08
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q